Cite
HARVARD Citation
Chiappori, A. et al. (n.d.). P860 Results from a combination of OX40 (PF-04518600) and 4–1BB (utomilumab) agonistic antibodies in melanoma and non-small cell lung cancer in a phase 1 dose expansion cohort. Journal for immunotherapy of cancer. pp. A9-A10. [Online].